Skip to main content

Prevention of Arterial Restenosis by Rapamycin and Mycophenolate Mofetil: A New Role for Novel Immunosuppressants in the Prevention of Post-Balloon Angioplasty Restenosis?

  • Conference paper
The Role of Immune Mechanisms in Cardiovascular Disease
  • 69 Accesses

Abstract

Angioplasty is a minimally invasive method for widening both stenotic coronary and peripheral atherosclerotic vessels. Restenosis is a late complication that affects almost 50% of vessels undergoing angioplasty within six months after the procedure (Nobuyoshi et al. 1988) and is characterized by vascular smooth muscle cell proliferation in the area of balloon catheter-induced injury. There has been a concerted effort to identify effective therapy for preventing or limiting this complication (Handley 1995), but despite a number of successful pharmacologic interventions in a variety of animal models of vascular injury, none of the agents (with perhaps the exception of angiopeptin (Eriksen et al. 1995)) has proven to be effective in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Allison AC, Eugui EM (1993) Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Transplant Proc 25–3 (Suppl 2): 8–18

    Google Scholar 

  • Allison AC, Eugui EM, Sollinger HW (1993) Mycophenolate mofetil (RS-61443): mechanisms of action and effects in transplantation. Transplant Rev 7 (3): 129–139

    Article  Google Scholar 

  • Ardehali A (1995) Heart transplantation: accelerated graft atherosclerosis. Adv Card Surg 6: 195–205

    PubMed  CAS  Google Scholar 

  • Billingham ME (1995) Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis. Transplant Proc 27 (3): 2013–2016

    PubMed  CAS  Google Scholar 

  • Calne RY, Lim S, Samaan A, Colier DSJ, Pollard SG, White DJG, Thiru S (1989) Rapamycin for immunosuppression in organ allografting. Lancet 2: 227

    Article  PubMed  CAS  Google Scholar 

  • Cao W, Mohacsi P, Shorthouse R, Pratt R, Morris RE (1995) Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis: inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. Transplantation 59 (3): 390–395

    PubMed  CAS  Google Scholar 

  • Cardenas ME, Zhu D, Heitman J (1995) Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr Opin in Nephrol Hypertens 4 (6): 472–477

    Article  CAS  Google Scholar 

  • Clowes AW, Clowes MM, Fingerle J, Reidy MA (1989) Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 14 (Suppl 6): S12–S15

    PubMed  Google Scholar 

  • Currier JW, Faxon DP (1995) Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 25: 516–520

    Article  PubMed  CAS  Google Scholar 

  • Eriksen UH, Amtorp O, Bagger JP, Emanuelsson H, Foegh M, Henningsen P, Saunamäki K, Schaeffer M, Thayssen P, Ørskov H, Kuntz RE, Popma JJ (1995) Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 130: 1–8

    Article  PubMed  CAS  Google Scholar 

  • Faxon DP, Currier JW (1995) Prevention of post-PTCA restenosis. Ann NY Acad Sci 748: 419–428

    Article  PubMed  CAS  Google Scholar 

  • Ferns G, Reidy M, Ross R (1990) Vascular effects of cyclosporine A in vivo and in vitro; Am J Pathol 137 (2): 403–413

    PubMed  CAS  Google Scholar 

  • Ferns GA, Reidy MA, Ross R (1991) Balloon catheter de-endothelialization of the nude rat carotid: response to injury in the absence of functional T lymphocytes. Am J Pathol 138 (4): 1045–1057

    PubMed  CAS  Google Scholar 

  • Franklin T, Cook JM (1969) The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 113: 358–363

    Google Scholar 

  • Gibbons GH, Dzau VJ (1994) The emerging concept of vascular remodeling. N Engl J Med 330 (20): 1431–1438

    Article  PubMed  CAS  Google Scholar 

  • Gregory CR, Pratt RE, Huie P, Shorthouse R, Dzau VJ, Billingham ME, Morris RE (1993a) Effects of treatment with cyclosporine, FK506, rapamycin, mycophenolic acid, or deox-yspergualin on vascular smooth muscle proliferation in vitro and in vivo. Transplant Proc 25-1 (1): 770–771

    Google Scholar 

  • Gregory CR, Huie P, Billingham ME, Morris RE (1993b) Rapamycin inhibits arterial intimai thickening caused by both alloimmune and mechanical injury: its effect on cellular, growth factor, and cytokine responses in injured vessels. Transplantation 55 (6): 1409–1418

    Article  PubMed  CAS  Google Scholar 

  • Gregory CR, Huang X, Pratt RE, Dzau VJ, Shorthouse R, Billingham ME, Morris RE (1995) Treatment with rapamycin and mycophenolic acid reduces arterial intimai thickening produced by mechanical injury and allows endothelial replacement. Transplantation 59 (5): 655–661

    Article  PubMed  CAS  Google Scholar 

  • Hancock WW, Adams DH, Wyner LR, Sayegh MH, Karnovsky MJ (1994) CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol 145 (5): 1008–1014

    PubMed  CAS  Google Scholar 

  • Handley DA (1995) Experimental therapeutics and clinical studies in (re)stenosis. Micron 26 (1): 51–68

    Article  PubMed  CAS  Google Scholar 

  • Hansson GK, Holm J, Holm S, Fotev Z, Hedrich H-J, Fingerle J (1991) T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA 88: 10530–10534

    Article  PubMed  CAS  Google Scholar 

  • Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemström K, Räisänen-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskinen E, Krogerus L, Aho P, Paavonen T (1993) Chronic allograft rejection. Immunol Rev 134: 33–81

    Article  PubMed  Google Scholar 

  • Kirklin JK, Bourge RC, Naftel DC, Morrow WR, Deierhoi MH, Kauffman RS, White-Williams C, Nomberg RI, Holman WL, Smith DC Jr. (1994) Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant 13: 444–450

    PubMed  CAS  Google Scholar 

  • Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK (1992) A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 86 (Suppl III): III-47–III-52

    CAS  Google Scholar 

  • Meiser BM, Billingham ME, Morris RE (1991) Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet 338: 1297–1298

    Article  PubMed  CAS  Google Scholar 

  • Morris RE (1991) Rapamycin: FK506’s fraternal twin or distant cousin? Immunol Today 12 (5): 137–140

    PubMed  CAS  Google Scholar 

  • Morris RE (1993) Prevention and treatment of allograft rejection in vivo by rapamycin: molecular and cellular mechanism of action. Ann NY Acad Sci 685: 68–72

    Article  PubMed  CAS  Google Scholar 

  • Morris RE (1996) Mechanisms of action of new immunosuppressive drugs. Kidney Int 49 (Suppl 53): S26–S38

    Google Scholar 

  • Morris RE, Meiser BM (1989) Identification of a new pharmacologic action for an old compound. Med Sci Res 17: 609–610

    CAS  Google Scholar 

  • Morris RE, Hoyt EG, Eugui EM, Allison AC (1989) Prolongation of rat heart allograft survival by RS-61443. Surg Forum 40: 337–338

    Google Scholar 

  • Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC (1990) Mycophenolic acid mor-pholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T-and B-cell purine synthesis. Transplant Proc 22 (4): 1659–1662

    PubMed  CAS  Google Scholar 

  • Morris RE, Meiser BM, Wu J, Shorthouse R, Wang J (1991a) Use of rapamycin for the suppression of alloimmune reactions in vivo: Schedule dependence, tolerance induction, synergy with cyclosporine and FK506, and effect on host-versus-graft and graft-versus-host reactions. Transplant Proc 23 (1): 521–524

    PubMed  CAS  Google Scholar 

  • Morris RE, Wang J, Blum JR, Flavin T, Murphy MP, Almquist SJ, Chu N, Tarn YL, Kaloostian M, Allison AC, Eugui EM (1991b) Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 23-2 (Suppl 2): 19–25

    Google Scholar 

  • Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H (1988) Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12 (3): 616–623

    PubMed  CAS  Google Scholar 

  • Popma JJ, Ellis St. G (1990) Intracoronary stents: clinical and angiographic results. Herz 15 (5): 307–318

    PubMed  CAS  Google Scholar 

  • Reidy MA, Jackson CL (1990) Factors controlling growth of arterial cells following injury. Toxicol Pathol 18-4 (1): 547–553

    Google Scholar 

  • Ross R (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57: 791–804

    Article  PubMed  CAS  Google Scholar 

  • Schwartz RS (1994) Neointima and arterial injury: dogs, rats, pigs, and more (editorial). Lab Invest 71 (6): 789–791

    PubMed  CAS  Google Scholar 

  • Sehgal S, Camardo JS, Scarola JA, Maida BT (1995) Rapamycin (sirolimus, rapamune). Curr Opin Nephrol Hypertens 4 (6): 482–487

    Article  PubMed  CAS  Google Scholar 

  • Steele DM, Hullett DA, Bechstein WO, Kowalski J, Smith LS, Kennedy E, Allison AC, Sollinger HW (1993) Effects of immunosuppressive therapy on the rat aortic allograft model. Transplant Proc 25 (1): 754–755

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nair, R.V., Gregory, C.R., Huang, X., Cao, W., Morris, R.E. (1997). Prevention of Arterial Restenosis by Rapamycin and Mycophenolate Mofetil: A New Role for Novel Immunosuppressants in the Prevention of Post-Balloon Angioplasty Restenosis?. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60463-8_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61358-9

  • Online ISBN: 978-3-642-60463-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics